Back to Side Effects

Black Triangle Medicines: What It Means

Black Triangle Medicines: What It Means
Prescription Medicines Editorial 7 June 2026

An inverted black triangle on a patient information leaflet or packaging means the medicine is under additional monitoring. It is not a warning that the medicine is dangerous or that anything has gone wrong. It means the safety picture is still being assembled - usually because the product is newly licensed, newly used in a different way, or a type of product where more data is wanted - and that reporting any suspected side effect is especially valuable.

The symbol is a request rather than a caution, and it is widely misread.

Why additional monitoring exists

Clinical trials establish that a medicine works and identify common side effects, but they are limited. They typically involve a few thousand people over months, and they exclude many of the people who will eventually take the drug - older people, those with several conditions, those on many other medicines, and often pregnant women.

A side effect affecting one in ten thousand people will not appear in a trial of two thousand. Nor will one that takes years to develop, or one that only occurs in combination with another drug. Those emerge only once large numbers of people are taking it in ordinary life.

Additional monitoring is the mechanism for catching them, and it depends on reports coming in. Our guide to how the Yellow Card scheme works covers the reporting system itself.

What gets a triangle

  • medicines containing a new active substance
  • biological medicines and biosimilars, where more experience is wanted
  • medicines given a conditional licence, or approved under exceptional circumstances
  • medicines where the company has been required to carry out further studies
  • existing medicines authorised for a new use or a new group of patients

The status is time-limited rather than permanent. Medicines typically carry the triangle for a defined period, often around five years from licensing, after which it is removed if nothing of concern has emerged.

So a triangle on a medicine you have taken for a while is not a new development, and its removal is not an announcement - it simply means the monitoring period has ended.

What it does not mean

It does not mean the medicine is less safe than others, or that it has been rushed through. It went through the same licensing process, and it would not be on the market if the benefits did not outweigh the known risks.

It is also not a reason to refuse a medicine. Every drug you take was under additional monitoring once, including the ones now considered thoroughly established.

If the symbol worries you, the useful response is to ask the prescriber why this medicine was chosen and what the alternatives are - a reasonable question about any prescription - rather than to decline on the basis of the triangle alone.

What to report, and how

For a triangle medicine, report any suspected side effect, however minor and whether or not it is already listed in the leaflet. That is a lower threshold than for established medicines, where the emphasis is on serious or unexpected effects.

Reports go through the MHRA Yellow Card website or app, or a paper form from a pharmacy. Patients and carers report directly - you do not need to go through a professional, and you do not need to be certain the medicine was responsible.

Include the brand name and batch number where you can, since these matter particularly for biological medicines, where different products are not identical. Keep the packaging until you have reported.

Biosimilars and batch numbers

Biological medicines are large, complex molecules produced in living cells rather than synthesised chemically, so a biosimilar is highly similar rather than identical to the original. That is why they are recorded by brand and batch, and why reports need that detail.

Our guide to why some medicines are prescribed by brand covers the group of medicines where the specific product matters rather than just the active ingredient.

Where to find the symbol

On the patient information leaflet, usually near the top, with a short sentence explaining it. Sometimes on the outer packaging. The MHRA also publishes a list of medicines currently under additional monitoring.

If you are starting something new and want to know, the leaflet is the quickest place to look - and the food and drink, driving and side effect sections are worth reading at the same time, as our guide to reading a medicine label explains.

Why bother reporting

Side effects are substantially under-reported everywhere, usually because people assume somebody else has done it, assume a mild effect does not matter, or are not certain the medicine was responsible. None of those holds up.

Several important safety changes have originated wholly or partly in patient reports. A few minutes contributes to what everyone else prescribing and taking that medicine knows about it - and for a triangle medicine, that contribution is at its most valuable.

Related reading: Side Effects in Children: What to Report, with more on side effects and safety in Side Effects.